arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

NutriBand Inc.

NTRB
$3.04 ▲ +0.21 (+7.61%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
42 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
8
Health
Poor
Bearish
auto_awesome

Analytical Summary

NutriBand Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $37.0M
Dividend Yield
Revenue Growth -35.1%
Op. Margin -289.4%
ROIC -16.5%
FCF / Share $-0.05
Trailing P/E
Price / Book 6.2x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

42-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$433.40K
↓ -35.1%
Net Income Profit after all expenses
$-1.24M
↑ +10.6%
Operating Margin Operating profit as % of sales
-289.4%
↓ -13.6% 0th
FCF / Share Free cash flow per share
$-0.05
↑ +61.6%
Long-Term Debt Long-term obligations
$1.70K
↓ -1.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
5
Financial Health
7
Cash Quality
40

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 42 quarters